Cafestol, a Coffee-Specific Diterpene, Is a Novel Extracellular Signal-Regulated Kinase Inhibitor with AP-1-Targeted Inhibition of Prostaglandin E-2 Production in Lipopolysaccharide-Activated Macrophages
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shen, Ting | - |
dc.contributor.author | Lee, Jaehwi | - |
dc.contributor.author | Lee, Eunji | - |
dc.contributor.author | Kim, Seong Hwan | - |
dc.contributor.author | Kim, Tae Woong | - |
dc.contributor.author | Cho, Jae Youl | - |
dc.date.available | 2019-05-30T02:24:13Z | - |
dc.date.issued | 2010-01 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.issn | 1347-5215 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/22709 | - |
dc.description.abstract | Coffee is a popular beverage worldwide with various nutritional benefits. Diterpene cafestol, one of the major components of coffee, contributes to its beneficial effects through various biological activities such as chemopreventive, antitumorigenic, hepatoprotective, antioxidative and antiinflammatory effects. In this study, we examined the precise molecular mechanism of the antiinflammatory activity of cafestol in terms of prostaglandin E-2 (PGE(2)) production, a critical factor involved in inflammatory responses. Cafestol inhibited both PGE(2) production and the mRNA expression of cyclooxygenase (COX)-2 from lipopolysaccharide (LPS)-treated RAW264.7 cells. Interestingly, this compound strongly decreased the translocation of c-Jun into the nucleus and AP-1 mediated luciferase activity. In kinase assays using purified extracellular signal-regulated kinase 2 (ERK2) or immunoprecipitated ERK prepared from LPS-treated cells in the presence or absence of cafestol, it was found that this compound can act as an inhibitor of ERK2 but not of ERK1 and mitogen-activated protein kinase kinase 1 (MEK 1). Therefore our data suggest that cafestol may be a novel ERK inhibitor with A-P-1-targeted inhibitory activity against PGE2 production in LPS-activated RAW264.7 cells. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.title | Cafestol, a Coffee-Specific Diterpene, Is a Novel Extracellular Signal-Regulated Kinase Inhibitor with AP-1-Targeted Inhibition of Prostaglandin E-2 Production in Lipopolysaccharide-Activated Macrophages | - |
dc.type | Article | - |
dc.identifier.doi | 10.1248/bpb.33.128 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.33, no.1, pp 128 - 132 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000273167800025 | - |
dc.identifier.scopusid | 2-s2.0-75149138360 | - |
dc.citation.endPage | 132 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 128 | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 33 | - |
dc.type.docType | Article | - |
dc.publisher.location | 일본 | - |
dc.subject.keywordAuthor | cafestol | - |
dc.subject.keywordAuthor | prostaglandin E-2 | - |
dc.subject.keywordAuthor | cyclooxygenase-2 | - |
dc.subject.keywordAuthor | AP-1 | - |
dc.subject.keywordAuthor | c-Jun | - |
dc.subject.keywordAuthor | extracellular signal-regulated kinase | - |
dc.subject.keywordPlus | CYCLOOXYGENASE-2 EXPRESSION | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | ERK INHIBITORS | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | KAHWEOL | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.